Please Wait.....
Report
Global Travel Vaccines Market Report and Forecast 2023-2031
Market Report I 2023-05-20 I 140 Pages I EMR Inc.
Global Travel Vaccines Market Report and Forecast 2023-2031
Global Travel Vaccines Market Outlook:
The global travel vaccines market value was USD 3.5 billion in 2022, driven by the increasing global mobility of individuals and the rising awareness of travel-related health risks across the globe. The market size is anticipated to grow at a CAGR of 10.7% during the forecast period of 2023-2031 to achieve a value of USD 8.6 billion by 2031.
Travel Vaccines: Introduction
Travel vaccines, also known as travel immunizations, are vaccines specifically designed to protect individuals from infectious diseases that may be prevalent in certain destinations or regions. When traveling internationally, individuals may come into contact with diseases that are not commonly encountered in their home country. Travel vaccines are essential in providing protection against these diseases and ensuring the health and safety of travelers.
The purpose of travel vaccines is to stimulate the immune system to produce a response against specific pathogens, such as viruses or bacteria, that are prevalent in the travel destination. These vaccines are formulated to provide immunity or reduce the severity of the disease if the individual is exposed to the pathogen during their travels.
Common travel vaccines include those for diseases such as hepatitis A and B, typhoid fever, yellow fever, meningococcal meningitis, Japanese encephalitis, and rabies, among others. The specific vaccines required will depend on the destination, the duration of travel, the individual's age, medical history, and any underlying health conditions.
Key Trends in the Travel Vaccines Market
Some of the key trends of the travel Vaccines market are:
- Increasing Emphasis on Personalized Travel Health Services: There is a growing trend toward personalized travel health services, where healthcare providers offer tailored advice and immunization plans based on the traveler's destination, duration of stay, and individual health considerations. This approach ensures that travelers receive the most appropriate vaccines and preventive measures based on their specific needs.
- Technological Advancements in Vaccine Delivery and Administration: The market is witnessing technological advancements in vaccine delivery systems, such as the development of needle-free or pain-free administration methods. These advancements aim to enhance patient convenience, improve vaccination adherence, and minimize needle-related anxieties.
- Rising Demand for Combination Vaccines: Combination vaccines, which provide protection against multiple diseases in a single shot, are gaining popularity in the travel vaccines market. These vaccines offer convenience to travelers by reducing the number of injections required and ensuring comprehensive protection against various diseases.
- Growing Focus on Vaccine Safety and Efficacy: There is an increasing emphasis on ensuring the safety and efficacy of travel vaccines. Vaccine manufacturers and regulatory authorities are closely monitoring and evaluating the performance of vaccines, conducting clinical trials, and implementing rigorous quality control measures to maintain high standards.
Travel Vaccines Market Segmentations
Market Breakup by Composition
- Mono Vaccines
- Combination Vaccines
Market Breakup by Disease
- Hepatitis A
- DPT
- Yellow Fever
- Typhoid
- Hepatitis B
- Measles and Mumps
- Rabies
- Meningococcal
- Varicella
- Japanese Encephalitis
- Others
Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Travel Vaccines Market Scenario
The travel vaccines market has experienced significant growth in recent years due to the increasing global mobility of individuals and the rising awareness of travel-related health risks. Travelers, especially those visiting regions with higher disease prevalence, are becoming more proactive in seeking appropriate immunizations to protect themselves during their trips. This has led to a surge in demand for travel vaccines and related services.
Travel vaccines, also known as travel immunizations, are vaccines specifically designed to protect individuals from infectious diseases that may be prevalent in certain destinations or regions. When traveling internationally, individuals may come into contact with diseases that are not commonly encountered in their home country. Travel vaccines are essential in providing protection against these diseases and ensuring the health and safety of travellers.
In recent years, there has been a rise in the demand for personalized travel medicine, with healthcare professionals offering tailored advice based on the individual's travel plans, medical history, and specific risk factors. This approach ensures that travellers receive the appropriate vaccines and health recommendations to minimize the risk of acquiring travel-related infections.
The market is primarily driven by factors such as the growing number of international travellers, the implementation of mandatory vaccine requirements by certain countries, and the efforts of healthcare organizations and governments to promote pre-travel health practices. Increasing globalization and ease of travel have also contributed to the expansion of the market, with more individuals exploring different parts of the world for leisure, business, and educational purposes.
Travel Vaccines Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Sanofi
- Pfizer Inc.
- CSL Limited
- Bavarian Nordic
- F. Hoffmann-La Roche Ltd
- Abbott
- Astrazeneca
- Bavarian Nordic
- Crucell
1 Preface
2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Travel Vaccines Market Analysis
8.1 Key Industry Highlights
8.2 Global Travel Vaccines Historical Market (2018-2022)
8.3 Global Travel Vaccines Market Forecast (2023-2028)
8.4 Global Travel Vaccines Market by Composition
8.4.1 Mono Vaccines
8.4.1.1 Historical Trend (2018-2022)
8.4.1.2 Forecast Trend (2023-2028)
8.4.2 Combination Vaccines
8.4.2.1 Historical Trend (2018-2022)
8.4.2.2 Forecast Trend (2023-2028)
8.5 Global Travel Vaccines Market by Disease
8.5.1 Hepatitis A
8.5.1.1 Historical Trend (2018-2022)
8.5.1.2 Forecast Trend (2023-2028)
8.5.2 DPT
8.5.2.1 Historical Trend (2018-2022)
8.5.2.2 Forecast Trend (2023-2028)
8.5.3 Yellow Fever
8.5.3.1 Historical Trend (2018-2022)
8.5.3.2 Forecast Trend (2023-2028)
8.5.4 Typhoid
8.5.4.1 Historical Trend (2018-2022)
8.5.4.2 Forecast Trend (2023-2028)
8.5.5 Hepatitis B
8.5.5.1 Historical Trend (2018-2022)
8.5.5.2 Forecast Trend (2023-2028)
8.5.6 Measles and Mumps
8.5.6.1 Historical Trend (2018-2022)
8.5.6.2 Forecast Trend (2023-2028)
8.5.7 Rabies
8.5.7.1 Historical Trend (2018-2022)
8.5.7.2 Forecast Trend (2023-2028)
8.5.8 Meningococcal
8.5.8.1 Historical Trend (2018-2022)
8.5.8.2 Forecast Trend (2023-2028)
8.5.9 Varicella
8.5.9.1 Historical Trend (2018-2022)
8.5.9.2 Forecast Trend (2023-2028)
8.5.10 Japanese Encephalitis
8.5.10.1 Historical Trend (2018-2022)
8.5.10.2 Forecast Trend (2023-2028)
8.5.11 Others
8.6 Global Travel Vaccines Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2018-2022)
8.6.1.2 Forecast Trend (2023-2028)
8.6.2 Europe
8.6.2.1 Historical Trend (2018-2022)
8.6.2.2 Forecast Trend (2023-2028)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2018-2022)
8.6.3.2 Forecast Trend (2023-2028)
8.6.4 Latin America
8.6.4.1 Historical Trend (2018-2022)
8.6.4.2 Forecast Trend (2023-2028)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2018-2022)
8.6.5.2 Forecast Trend (2023-2028)
9 North America Travel Vaccines Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
10 Europe Travel Vaccines Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2022)
10.1.2 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Historical Trend (2018-2022)
10.2.2 Forecast Trend (2023-2028)
10.3 France
10.3.1 Historical Trend (2018-2022)
10.3.2 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Historical Trend (2018-2022)
10.4.2 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Travel Vaccines Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2022)
11.1.2 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Historical Trend (2018-2022)
11.2.2 Forecast Trend (2023-2028)
11.3 India
11.3.1 Historical Trend (2018-2022)
11.3.2 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Historical Trend (2018-2022)
11.4.2 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Historical Trend (2018-2022)
11.5.2 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Travel Vaccines Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2022)
12.1.2 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Historical Trend (2018-2022)
12.2.2 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Historical Trend (2018-2022)
12.3.2 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Travel Vaccines Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2022)
13.1.2 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2022)
13.2.2 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Historical Trend (2018-2022)
13.3.2 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Historical Trend (2018-2022)
13.4.2 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter's Five Forces Analysis
14.2.1 Supplier's Power
14.2.2 Buyer's Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Manufacturing Process
16.1 Overview
16.2 Detailed Process Flow
16.3 Operation Involved
17 Competitive Landscape
17.1 Market Structure
17.2 Company Profiles
17.2.1 GlaxoSmithKline plc.
17.2.1.1 Company Overview
17.2.1.2 Product Portfolio
17.2.1.3 Demographic Reach and Achievements
17.2.1.4 Certifications
17.2.2 Merck & Co., Inc.
17.2.2.1 Company Overview
17.2.2.2 Product Portfolio
17.2.2.3 Demographic Reach and Achievements
17.2.2.4 Certifications
17.2.3 Sanofi
17.2.3.1 Company Overview
17.2.3.2 Product Portfolio
17.2.3.3 Demographic Reach and Achievements
17.2.3.4 Certifications
17.2.4 Pfizer Inc.
17.2.4.1 Company Overview
17.2.4.2 Product Portfolio
17.2.4.3 Demographic Reach and Achievements
17.2.4.4 Certifications
17.2.5 CSL Limited
17.2.5.1 Company Overview
17.2.5.2 Product Portfolio
17.2.5.3 Demographic Reach and Achievements
17.2.5.4 Certifications
17.3.6 Others
18 Key Trends and Developments in the Market
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security